This IV therapy is commonly used by clients seeking support for: While Glutathione IV Therapy may support detoxification and antioxidant protection, it is not intended to diagnose, treat, or cure medical conditions
Published literature includes papers in journals such as: Nature, Pain, PNS, Blood, BMJ, Spine, Muscle and Nerve, The Lancet, Circulation and BJSM Around 30 LLLT papers published per month Over 4000 laboratory studies and over 400 randomised controlled trials Over 2,500 clinical studies and published research reports have investigated the use of LLLT/PBMT across a variety of health issues
Glutathione reductase and thioredoxin reductase at the crossroad: The structure of Schistosoma mansoni thioredoxin glutathione reductase
Because they operate more like manufacturers, 503B facilities must register with the FDA and follow stringent Current Good Manufacturing Practices (cGMP) requirements, which are the same standards drug manufacturers must meet
This reference is useful for patients comparing physician perspectives
Systematic review of effectiveness of situated e-learning on medical and nursing education
